JZP341 Phase 1 Dose-Finding Study in Adult Participants With Advanced or Metastatic Solid Tumors

Status:
Not yet recruiting

Trial end date:
2027-11-29

Target enrollment:

Participant gender:

This study will assess the safety and efficacy of JZP341 in participants with advanced or metastatic solid tumors.

Phase 1

Jazz Pharmaceuticals